Hepion Pharmaceuticals Stock Forecast
| Recent Hepion Pharmaceuticals Stock Price | Hepion Pharmaceuticals Stock Forecast Price | |
| $2.11 |  -100.00% |
$0.00 |
| Recent Hepion Pharmaceuticals Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 0 | 0 | 0 | 0 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 1 | 1 | 1 | 1 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 3.0 | 3.0 | 3.0 | 3.0 |
The presented Hepion Pharmaceuticals stock forecast (traded under symbol HEPA), for forward-twelve-months price target as shown at the top of this page, gives you the average Hepion Pharmaceuticals stock forecast for forward target price for symbol HEPA, across the analysts covering Hepion Pharmaceuticals (HEPA), as reported in data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Hepion Pharmaceuticals stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Hepion Pharmaceuticals stock forecast and half had a lower Hepion Pharmaceuticals stock forecast) was $ as of 2024-04-19 (which is a different mathematical metric versus taking the average or mean), while the
highest Hepion Pharmaceuticals stock forecast in the analyst group was $, and the lowest Hepion Pharmaceuticals stock forecast in the analyst group was
$, with a standard deviation of $. Get the latest Zacks research report on HEPA — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
|
|||||||||||||||||||||
|
|
|
 Free HEPA Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Hold (2.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
|
|
